These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels. Guillaumet-Adkins A; Richter J; Odero MD; Sandoval J; Agirre X; Catala A; Esteller M; Prósper F; Calasanz MJ; Buño I; Kwon M; Court F; Siebert R; Monk D J Hematol Oncol; 2014 Jan; 7():4. PubMed ID: 24405639 [TBL] [Abstract][Full Text] [Related]
48. Expression of Pax5 gene in human haematopoietic cells and tissues: comparison with immunodeficient donors. Kaneko H; Ariyasu T; Inoue R; Fukao T; Kasahara K; Teramoto T; Matsui E; Hayakawa S; Kondo N Clin Exp Immunol; 1998 Feb; 111(2):339-44. PubMed ID: 9486401 [TBL] [Abstract][Full Text] [Related]
49. Bi-phenotypic t(9;22)-positive leukemia cell lines from a patient with acute leukemia: NALM-20, established at the onset; and NALM-21, NALM-22 and NALM-23, established after relapse. Matsuo Y; Ariyasu T; Ohmoto E; Kimura I; Minowada J Hum Cell; 1991 Dec; 4(4):335-8. PubMed ID: 1817649 [TBL] [Abstract][Full Text] [Related]
50. Two t(9;22) leukemia cell lines (NALM-24 and NALM-25) with bi-phenotypic characteristics and an EBV-positive B-cell non-leukemia cell line (B262) established from a patient with acute lymphoblastic leukemia. Matsuo Y; Ariyasu T; Adachi T; Tsubota T; Minowada J Hum Cell; 1991 Dec; 4(4):339-42. PubMed ID: 1667895 [TBL] [Abstract][Full Text] [Related]